Katharina Buczek
Moreover, the team realized that administering rapamycin early in adulthood provides the most robust and successful results as compared to middle age treatment.
So now, the researchers believe they may have a viable solution to age-related ailments that could be practically applied to humans.
Still, though, Linda Partridge, the study’s senior author, underscored that there are still many questions to answer.
“It will be important to discover whether it is possible to achieve the geroprotective efforts of rapamycin in mice and in humans with treatment starting later in life since, ideally, the period of treatment should be minimized. It may be possible also to use intermittent dosing,” Partridge said.
“This study has opened new doors but also raised many questions.”
To read the study’s complete findings, which have since been published in Nature Aging, visit the link here.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe.
New Research Finds Why Narcissists Are More Likely To Believe In Conspiracy Theories
She Received A “Wellness Check” From Her Local Book Store After Ordering Two Dark Novels
